The global market for Dimethyl Fumarate Delayed-release Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Dimethyl fumarate delayed-release capsules are a prescription medication used primarily to treat multiple sclerosis. The capsules contain dimethyl fumarate, which has anti-inflammatory and neuroprotective properties.

North American market for Dimethyl Fumarate Delayed-release Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Dimethyl Fumarate Delayed-release Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Dimethyl Fumarate Delayed-release Capsules include Biogen, Mylan, Neuraxpharm, Hexal AG, Accord Healthcare, Polpharma, Teva Pharmaceutical, Glenmark Pharmaceuticals, Cipla, Lupin, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dimethyl Fumarate Delayed-release Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dimethyl Fumarate Delayed-release Capsules.

The Dimethyl Fumarate Delayed-release Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dimethyl Fumarate Delayed-release Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dimethyl Fumarate Delayed-release Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dimethyl Fumarate Delayed-release Capsules Market Report

Report Metric	Details
Report Name	Dimethyl Fumarate Delayed-release Capsules Market
Segment by Type	120mg per Unit 240mg per Unit
Segment by Application	Hospital and Clinic Pharmacy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Biogen, Mylan, Neuraxpharm, Hexal AG, Accord Healthcare, Polpharma, Teva Pharmaceutical, Glenmark Pharmaceuticals, Cipla, Lupin, Qilu Pharmaceutical, Sichuan Omnis Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dimethyl Fumarate Delayed-release Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dimethyl Fumarate Delayed-release Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Dimethyl Fumarate Delayed-release Capsules Market report?

Ans: The main players in the Dimethyl Fumarate Delayed-release Capsules Market are Biogen, Mylan, Neuraxpharm, Hexal AG, Accord Healthcare, Polpharma, Teva Pharmaceutical, Glenmark Pharmaceuticals, Cipla, Lupin, Qilu Pharmaceutical, Sichuan Omnis Pharmaceutical

What are the Application segmentation covered in the Dimethyl Fumarate Delayed-release Capsules Market report?

Ans: The Applications covered in the Dimethyl Fumarate Delayed-release Capsules Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Dimethyl Fumarate Delayed-release Capsules Market report?

Ans: The Types covered in the Dimethyl Fumarate Delayed-release Capsules Market report are 120mg per Unit, 240mg per Unit

1 Dimethyl Fumarate Delayed-release Capsules Market Overview

1.1 Product Definition

1.2 Dimethyl Fumarate Delayed-release Capsules by Type

1.2.1 Global Dimethyl Fumarate Delayed-release Capsules Market Value Comparison by Type (2024 VS 2031)

1.2.2 120mg per Unit

1.2.3 240mg per Unit

1.3 Dimethyl Fumarate Delayed-release Capsules by Application

1.3.1 Global Dimethyl Fumarate Delayed-release Capsules Market Value by Application (2024 VS 2031)

1.3.2 Hospital and Clinic

1.3.3 Pharmacy

1.3.4 Other

1.4 Global Dimethyl Fumarate Delayed-release Capsules Market Size Estimates and Forecasts

1.4.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue 2020-2031

1.4.2 Global Dimethyl Fumarate Delayed-release Capsules Sales 2020-2031

1.4.3 Global Dimethyl Fumarate Delayed-release Capsules Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Dimethyl Fumarate Delayed-release Capsules Market Competition by Manufacturers

2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Manufacturers (2020-2025)

2.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Dimethyl Fumarate Delayed-release Capsules Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Dimethyl Fumarate Delayed-release Capsules, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Dimethyl Fumarate Delayed-release Capsules, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Dimethyl Fumarate Delayed-release Capsules, Product Type & Application

2.7 Global Key Manufacturers of Dimethyl Fumarate Delayed-release Capsules, Date of Enter into This Industry

2.8 Global Dimethyl Fumarate Delayed-release Capsules Market Competitive Situation and Trends

2.8.1 Global Dimethyl Fumarate Delayed-release Capsules Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Dimethyl Fumarate Delayed-release Capsules Players Market Share by Revenue

2.8.3 Global Dimethyl Fumarate Delayed-release Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Dimethyl Fumarate Delayed-release Capsules Market Scenario by Region

3.1 Global Dimethyl Fumarate Delayed-release Capsules Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region: 2020-2031

3.2.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region: 2020-2025

3.2.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Region: 2026-2031

3.3 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region: 2020-2031

3.3.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region: 2020-2025

3.3.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region: 2026-2031

3.4 North America Dimethyl Fumarate Delayed-release Capsules Market Facts & Figures by Country

3.4.1 North America Dimethyl Fumarate Delayed-release Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2031)

3.4.3 North America Dimethyl Fumarate Delayed-release Capsules Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Dimethyl Fumarate Delayed-release Capsules Market Facts & Figures by Country

3.5.1 Europe Dimethyl Fumarate Delayed-release Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2031)

3.5.3 Europe Dimethyl Fumarate Delayed-release Capsules Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Dimethyl Fumarate Delayed-release Capsules Market Facts & Figures by Region

3.6.1 Asia Pacific Dimethyl Fumarate Delayed-release Capsules Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Dimethyl Fumarate Delayed-release Capsules Sales by Region (2020-2031)

3.6.3 Asia Pacific Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Dimethyl Fumarate Delayed-release Capsules Market Facts & Figures by Country

3.7.1 Latin America Dimethyl Fumarate Delayed-release Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2031)

3.7.3 Latin America Dimethyl Fumarate Delayed-release Capsules Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Market Facts & Figures by Country

3.8.1 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2031)

3.8.3 Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2020-2031)

4.1.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2020-2025)

4.1.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Type (2026-2031)

4.1.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Type (2020-2031)

4.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2020-2031)

4.2.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2020-2025)

4.2.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Type (2026-2031)

4.2.3 Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Type (2020-2031)

4.3 Global Dimethyl Fumarate Delayed-release Capsules Price by Type (2020-2031)

5 Segment by Application

5.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2020-2031)

5.1.1 Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2020-2025)

5.1.2 Global Dimethyl Fumarate Delayed-release Capsules Sales by Application (2026-2031)

5.1.3 Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Application (2020-2031)

5.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2020-2031)

5.2.1 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2020-2025)

5.2.2 Global Dimethyl Fumarate Delayed-release Capsules Revenue by Application (2026-2031)

5.2.3 Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Application (2020-2031)

5.3 Global Dimethyl Fumarate Delayed-release Capsules Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Biogen

6.1.1 Biogen Company Information

6.1.2 Biogen Description and Business Overview

6.1.3 Biogen Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Biogen Dimethyl Fumarate Delayed-release Capsules Product Portfolio

6.1.5 Biogen Recent Developments/Updates

6.2 Mylan

6.2.1 Mylan Company Information

6.2.2 Mylan Description and Business Overview

6.2.3 Mylan Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Mylan Dimethyl Fumarate Delayed-release Capsules Product Portfolio

6.2.5 Mylan Recent Developments/Updates

6.3 Neuraxpharm

6.3.1 Neuraxpharm Company Information

6.3.2 Neuraxpharm Description and Business Overview

6.3.3 Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Product Portfolio

6.3.5 Neuraxpharm Recent Developments/Updates

6.4 Hexal AG

6.4.1 Hexal AG Company Information

6.4.2 Hexal AG Description and Business Overview

6.4.3 Hexal AG Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Hexal AG Dimethyl Fumarate Delayed-release Capsules Product Portfolio

6.4.5 Hexal AG Recent Developments/Updates

6.5 Accord Healthcare

6.5.1 Accord Healthcare Company Information

6.5.2 Accord Healthcare Description and Business Overview

6.5.3 Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Product Portfolio

6.5.5 Accord Healthcare Recent Developments/Updates

6.6 Polpharma

6.6.1 Polpharma Company Information

6.6.2 Polpharma Description and Business Overview

6.6.3 Polpharma Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Polpharma Dimethyl Fumarate Delayed-release Capsules Product Portfolio

6.6.5 Polpharma Recent Developments/Updates

6.7 Teva Pharmaceutical

6.7.1 Teva Pharmaceutical Company Information

6.7.2 Teva Pharmaceutical Description and Business Overview

6.7.3 Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio

6.7.5 Teva Pharmaceutical Recent Developments/Updates

6.8 Glenmark Pharmaceuticals

6.8.1 Glenmark Pharmaceuticals Company Information

6.8.2 Glenmark Pharmaceuticals Description and Business Overview

6.8.3 Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Product Portfolio

6.8.5 Glenmark Pharmaceuticals Recent Developments/Updates

6.9 Cipla

6.9.1 Cipla Company Information

6.9.2 Cipla Description and Business Overview

6.9.3 Cipla Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Cipla Dimethyl Fumarate Delayed-release Capsules Product Portfolio

6.9.5 Cipla Recent Developments/Updates

6.10 Lupin

6.10.1 Lupin Company Information

6.10.2 Lupin Description and Business Overview

6.10.3 Lupin Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Lupin Dimethyl Fumarate Delayed-release Capsules Product Portfolio

6.10.5 Lupin Recent Developments/Updates

6.11 Qilu Pharmaceutical

6.11.1 Qilu Pharmaceutical Company Information

6.11.2 Qilu Pharmaceutical Description and Business Overview

6.11.3 Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio

6.11.5 Qilu Pharmaceutical Recent Developments/Updates

6.12 Sichuan Omnis Pharmaceutical

6.12.1 Sichuan Omnis Pharmaceutical Company Information

6.12.2 Sichuan Omnis Pharmaceutical Description and Business Overview

6.12.3 Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product Portfolio

6.12.5 Sichuan Omnis Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Dimethyl Fumarate Delayed-release Capsules Industry Chain Analysis

7.2 Dimethyl Fumarate Delayed-release Capsules Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Dimethyl Fumarate Delayed-release Capsules Production Mode & Process Analysis

7.4 Dimethyl Fumarate Delayed-release Capsules Sales and Marketing

7.4.1 Dimethyl Fumarate Delayed-release Capsules Sales Channels

7.4.2 Dimethyl Fumarate Delayed-release Capsules Distributors

7.5 Dimethyl Fumarate Delayed-release Capsules Customer Analysis

8 Dimethyl Fumarate Delayed-release Capsules Market Dynamics

8.1 Dimethyl Fumarate Delayed-release Capsules Industry Trends

8.2 Dimethyl Fumarate Delayed-release Capsules Market Drivers

8.3 Dimethyl Fumarate Delayed-release Capsules Market Challenges

8.4 Dimethyl Fumarate Delayed-release Capsules Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Glenmark Pharmaceuticals

Cipla Ltd

Lupin Ltd

Qilu Pharmaceutical

Sichuan Omnis Pharmaceutical

Biogen

List of Tables

Table 1. Global Dimethyl Fumarate Delayed-release Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Dimethyl Fumarate Delayed-release Capsules Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Dimethyl Fumarate Delayed-release Capsules Market Competitive Situation by Manufacturers in 2024

Table 4. Global Dimethyl Fumarate Delayed-release Capsules Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Dimethyl Fumarate Delayed-release Capsules Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Dimethyl Fumarate Delayed-release Capsules Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Dimethyl Fumarate Delayed-release Capsules Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Dimethyl Fumarate Delayed-release Capsules, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Dimethyl Fumarate Delayed-release Capsules, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Dimethyl Fumarate Delayed-release Capsules, Product Type & Application

Table 12. Global Key Manufacturers of Dimethyl Fumarate Delayed-release Capsules, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Dimethyl Fumarate Delayed-release Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dimethyl Fumarate Delayed-release Capsules as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Dimethyl Fumarate Delayed-release Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2020-2025) & (K Units)

Table 18. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Region (2020-2025)

Table 19. Global Dimethyl Fumarate Delayed-release Capsules Sales by Region (2026-2031) & (K Units)

Table 20. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Region (2026-2031)

Table 21. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Region (2020-2025)

Table 23. Global Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Region (2026-2031)

Table 25. North America Dimethyl Fumarate Delayed-release Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2025) & (K Units)

Table 27. North America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2026-2031) & (K Units)

Table 28. North America Dimethyl Fumarate Delayed-release Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Dimethyl Fumarate Delayed-release Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Dimethyl Fumarate Delayed-release Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2025) & (K Units)

Table 32. Europe Dimethyl Fumarate Delayed-release Capsules Sales by Country (2026-2031) & (K Units)

Table 33. Europe Dimethyl Fumarate Delayed-release Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Dimethyl Fumarate Delayed-release Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Dimethyl Fumarate Delayed-release Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Dimethyl Fumarate Delayed-release Capsules Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Dimethyl Fumarate Delayed-release Capsules Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Dimethyl Fumarate Delayed-release Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Dimethyl Fumarate Delayed-release Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Dimethyl Fumarate Delayed-release Capsules Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Dimethyl Fumarate Delayed-release Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Dimethyl Fumarate Delayed-release Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Dimethyl Fumarate Delayed-release Capsules Sales (K Units) by Type (2020-2025)

Table 51. Global Dimethyl Fumarate Delayed-release Capsules Sales (K Units) by Type (2026-2031)

Table 52. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Type (2020-2025)

Table 53. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Type (2026-2031)

Table 54. Global Dimethyl Fumarate Delayed-release Capsules Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Dimethyl Fumarate Delayed-release Capsules Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Type (2020-2025)

Table 57. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Type (2026-2031)

Table 58. Global Dimethyl Fumarate Delayed-release Capsules Price (US$/Unit) by Type (2020-2025)

Table 59. Global Dimethyl Fumarate Delayed-release Capsules Price (US$/Unit) by Type (2026-2031)

Table 60. Global Dimethyl Fumarate Delayed-release Capsules Sales (K Units) by Application (2020-2025)

Table 61. Global Dimethyl Fumarate Delayed-release Capsules Sales (K Units) by Application (2026-2031)

Table 62. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Application (2020-2025)

Table 63. Global Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Application (2026-2031)

Table 64. Global Dimethyl Fumarate Delayed-release Capsules Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Dimethyl Fumarate Delayed-release Capsules Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Application (2020-2025)

Table 67. Global Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Application (2026-2031)

Table 68. Global Dimethyl Fumarate Delayed-release Capsules Price (US$/Unit) by Application (2020-2025)

Table 69. Global Dimethyl Fumarate Delayed-release Capsules Price (US$/Unit) by Application (2026-2031)

Table 70. Biogen Company Information

Table 71. Biogen Description and Business Overview

Table 72. Biogen Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Biogen Dimethyl Fumarate Delayed-release Capsules Product

Table 74. Biogen Recent Developments/Updates

Table 75. Mylan Company Information

Table 76. Mylan Description and Business Overview

Table 77. Mylan Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Mylan Dimethyl Fumarate Delayed-release Capsules Product

Table 79. Mylan Recent Developments/Updates

Table 80. Neuraxpharm Company Information

Table 81. Neuraxpharm Description and Business Overview

Table 82. Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Neuraxpharm Dimethyl Fumarate Delayed-release Capsules Product

Table 84. Neuraxpharm Recent Developments/Updates

Table 85. Hexal AG Company Information

Table 86. Hexal AG Description and Business Overview

Table 87. Hexal AG Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Hexal AG Dimethyl Fumarate Delayed-release Capsules Product

Table 89. Hexal AG Recent Developments/Updates

Table 90. Accord Healthcare Company Information

Table 91. Accord Healthcare Description and Business Overview

Table 92. Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Accord Healthcare Dimethyl Fumarate Delayed-release Capsules Product

Table 94. Accord Healthcare Recent Developments/Updates

Table 95. Polpharma Company Information

Table 96. Polpharma Description and Business Overview

Table 97. Polpharma Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Polpharma Dimethyl Fumarate Delayed-release Capsules Product

Table 99. Polpharma Recent Developments/Updates

Table 100. Teva Pharmaceutical Company Information

Table 101. Teva Pharmaceutical Description and Business Overview

Table 102. Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Teva Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product

Table 104. Teva Pharmaceutical Recent Developments/Updates

Table 105. Glenmark Pharmaceuticals Company Information

Table 106. Glenmark Pharmaceuticals Description and Business Overview

Table 107. Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Glenmark Pharmaceuticals Dimethyl Fumarate Delayed-release Capsules Product

Table 109. Glenmark Pharmaceuticals Recent Developments/Updates

Table 110. Cipla Company Information

Table 111. Cipla Description and Business Overview

Table 112. Cipla Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Cipla Dimethyl Fumarate Delayed-release Capsules Product

Table 114. Cipla Recent Developments/Updates

Table 115. Lupin Company Information

Table 116. Lupin Description and Business Overview

Table 117. Lupin Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Lupin Dimethyl Fumarate Delayed-release Capsules Product

Table 119. Lupin Recent Developments/Updates

Table 120. Qilu Pharmaceutical Company Information

Table 121. Qilu Pharmaceutical Description and Business Overview

Table 122. Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Qilu Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product

Table 124. Qilu Pharmaceutical Recent Developments/Updates

Table 125. Sichuan Omnis Pharmaceutical Company Information

Table 126. Sichuan Omnis Pharmaceutical Description and Business Overview

Table 127. Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Sichuan Omnis Pharmaceutical Dimethyl Fumarate Delayed-release Capsules Product

Table 129. Sichuan Omnis Pharmaceutical Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Dimethyl Fumarate Delayed-release Capsules Distributors List

Table 133. Dimethyl Fumarate Delayed-release Capsules Customers List

Table 134. Dimethyl Fumarate Delayed-release Capsules Market Trends

Table 135. Dimethyl Fumarate Delayed-release Capsules Market Drivers

Table 136. Dimethyl Fumarate Delayed-release Capsules Market Challenges

Table 137. Dimethyl Fumarate Delayed-release Capsules Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Dimethyl Fumarate Delayed-release Capsules

Figure 2. Global Dimethyl Fumarate Delayed-release Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Dimethyl Fumarate Delayed-release Capsules Market Share by Type: 2024 & 2031

Figure 4. 120mg per Unit Product Picture

Figure 5. 240mg per Unit Product Picture

Figure 6. Global Dimethyl Fumarate Delayed-release Capsules Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Dimethyl Fumarate Delayed-release Capsules Market Share by Application: 2024 & 2031

Figure 8. Hospital and Clinic

Figure 9. Pharmacy

Figure 10. Other

Figure 11. Global Dimethyl Fumarate Delayed-release Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Dimethyl Fumarate Delayed-release Capsules Market Size (2020-2031) & (US$ Million)

Figure 13. Global Dimethyl Fumarate Delayed-release Capsules Sales (2020-2031) & (K Units)

Figure 14. Global Dimethyl Fumarate Delayed-release Capsules Average Price (US$/Unit) & (2020-2031)

Figure 15. Dimethyl Fumarate Delayed-release Capsules Report Years Considered

Figure 16. Dimethyl Fumarate Delayed-release Capsules Sales Share by Manufacturers in 2024

Figure 17. Global Dimethyl Fumarate Delayed-release Capsules Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Dimethyl Fumarate Delayed-release Capsules Players: Market Share by Revenue in Dimethyl Fumarate Delayed-release Capsules in 2024

Figure 19. Dimethyl Fumarate Delayed-release Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Dimethyl Fumarate Delayed-release Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Country (2020-2031)

Figure 22. North America Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Country (2020-2031)

Figure 23. United States Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Country (2020-2031)

Figure 26. Europe Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Country (2020-2031)

Figure 27. Germany Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Region (2020-2031)

Figure 34. China Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Country (2020-2031)

Figure 42. Latin America Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Dimethyl Fumarate Delayed-release Capsules Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Dimethyl Fumarate Delayed-release Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Dimethyl Fumarate Delayed-release Capsules by Type (2020-2031)

Figure 53. Global Revenue Market Share of Dimethyl Fumarate Delayed-release Capsules by Type (2020-2031)

Figure 54. Global Dimethyl Fumarate Delayed-release Capsules Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Dimethyl Fumarate Delayed-release Capsules by Application (2020-2031)

Figure 56. Global Revenue Market Share of Dimethyl Fumarate Delayed-release Capsules by Application (2020-2031)

Figure 57. Global Dimethyl Fumarate Delayed-release Capsules Price (US$/Unit) by Application (2020-2031)

Figure 58. Dimethyl Fumarate Delayed-release Capsules Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions